Ethics and regulatory complexities for pragmatic clinical trials.
Publication
, Journal Article
Sugarman, J; Califf, RM
Published in: JAMA
June 18, 2014
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
June 18, 2014
Volume
311
Issue
23
Start / End Page
2381 / 2382
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Risk Assessment
- Research Subjects
- Pragmatic Clinical Trials as Topic
- Off-Label Use
- Informed Consent
- Humans
- Government Regulation
- General & Internal Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Sugarman, J., & Califf, R. M. (2014). Ethics and regulatory complexities for pragmatic clinical trials. JAMA, 311(23), 2381–2382. https://doi.org/10.1001/jama.2014.4164
Sugarman, Jeremy, and Robert M. Califf. “Ethics and regulatory complexities for pragmatic clinical trials.” JAMA 311, no. 23 (June 18, 2014): 2381–82. https://doi.org/10.1001/jama.2014.4164.
Sugarman J, Califf RM. Ethics and regulatory complexities for pragmatic clinical trials. JAMA. 2014 Jun 18;311(23):2381–2.
Sugarman, Jeremy, and Robert M. Califf. “Ethics and regulatory complexities for pragmatic clinical trials.” JAMA, vol. 311, no. 23, June 2014, pp. 2381–82. Pubmed, doi:10.1001/jama.2014.4164.
Sugarman J, Califf RM. Ethics and regulatory complexities for pragmatic clinical trials. JAMA. 2014 Jun 18;311(23):2381–2382.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
June 18, 2014
Volume
311
Issue
23
Start / End Page
2381 / 2382
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Risk Assessment
- Research Subjects
- Pragmatic Clinical Trials as Topic
- Off-Label Use
- Informed Consent
- Humans
- Government Regulation
- General & Internal Medicine